Chargement en cours...
Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.
The relatively restricted use of hormone replacement therapy in the United Kingdom has frequently been noted. It is possible that low prescribing rates may, in part, be due to the difficulty in interpreting the wealth of research evidence relating to the risks and benefits of hormone replacement the...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
1992
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1371997/ https://ncbi.nlm.nih.gov/pubmed/1493029 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|